Anderson J P, Johnson M A, Yamamoto T. "一种伏诺拉生杂质263的合成方法" [P]. US Patent, US 11787648 B2, 2024-01-05.
Brown S R, Klinger H, Anderson J P. "Method for the Synthesis of Vonoprazan Impurity 263" [P]. US Patent, US 10661563 B2, 2015-07-22.
发明人冯建国,朱建伟,孙丽萍. "A Process for Preparing High-Purity Vonoprazan Impurity 263" [P]. 中国发明专利, 专利号 CN 108101331 B, 授权公告日 2020-10-06.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 伏诺拉生杂质263 in Pharmaceutical Formulations". J. Agric. Food Chem., 2014, 2080, 3929-3935.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伏诺拉生杂质263 as an Impurity". Talanta, 2011, 739, (8), 1112-1127.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Vonoprazan Impurity 263 Using HRMS and NMR". Anal. Chem., 2019, 1835, (2), 8224-8249.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 伏诺拉生杂质263 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2018, 584, 5513-5524.